Reply to: Comments on "Finding the optimal mammography screening strategy: A cost-effectiveness analysis of 920 modeled strategies"
- PMID: 35460077
- PMCID: PMC9324213
- DOI: 10.1002/ijc.34042
Reply to: Comments on "Finding the optimal mammography screening strategy: A cost-effectiveness analysis of 920 modeled strategies"
Conflict of interest statement
The authors declare no conflict of interest.
Comment on
-
Finding the optimal mammography screening strategy: A cost-effectiveness analysis of 920 modelled strategies.Int J Cancer. 2022 Jul 15;151(2):287-296. doi: 10.1002/ijc.34000. Epub 2022 Mar 21. Int J Cancer. 2022. PMID: 35285018 Free PMC article.
-
Comments on "Finding the optimal mammography screening strategy: A cost-effectiveness analysis of 920 modeled strategies".Int J Cancer. 2022 Aug 15;151(4):649-650. doi: 10.1002/ijc.34043. Epub 2022 May 6. Int J Cancer. 2022. PMID: 35460074 No abstract available.
References
-
- de Gelder R, Heijnsdijk EA, Fracheboud J, Draisma G, de Koning HJ. The effects of population‐based mammography screening starting between age 40 and 50 in the presence of adjuvant systemic therapy. Int J Cancer. 2015;137:165‐172. - PubMed
-
- Paci E, Group EW. Summary of the evidence of breast cancer service screening outcomes in Europe and first estimate of the benefit and harm balance sheet. J Med Screen. 2012;19(Suppl 1):5‐13. - PubMed
-
- Bulliard JL, Beau AB, Njor S, et al. Breast cancer screening and overdiagnosis. Int J Cancer. 2021;149:846‐853. - PubMed
-
- de Haes JC, de Koning HJ, van Oortmarssen GJ, van Agt HM, de Bruyn AE, van Der Maas PJ. The impact of a breast cancer screening programme on quality‐adjusted life‐years. Int J Cancer. 1991;49:538‐544. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
